Concepedia

Jonas G. Barlind

JG

Statistics

Publications

3

Citations

106

H-Index

3

Active since

2012

Affiliations

AstraZeneca (Sweden)(Current)

AstraZeneca (United Kingdom)

Jonas G. Barlind is an author at AstraZeneca (Sweden) specializing in drug discovery, pharmacology, and pharmacy.

Publications per year

2012–2014

3

Publications

3

Discovery of AZD6642, an Inhibitor of 5-Lipoxygenase Activating Protein (FLAP) for the Treatment of Inflammatory Diseases

Malin Lemurell, Johan Ulander, Susanne Winiwarter et al. · Journal of Medicinal Chemistry · 2014 · 38 citations

, , +16

Design and Optimization of Pyrazinecarboxamide-Based Inhibitors of Diacylglycerol Acyltransferase 1 (DGAT1) Leading to a Clinical Candidate Dimethylpyrazinecarboxamide Phenylcyclohexylacetic Acid (AZD7687)

Jonas G. Barlind, Udo Bauer, Alan M. Birch et al. · Journal of Medicinal Chemistry · 2012 · 37 citations · Full text

, , +17

Identification and design of a novel series of MGAT2 inhibitors

Jonas G. Barlind, Linda K. Buckett, Sharon G. Crosby et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 31 citations · Full text

, , +6

1–3 of 3